Cargando…

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?

Detalles Bibliográficos
Autores principales:	Kim, Yeon-Ji, Chung, Woo Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214357/ https://www.ncbi.nlm.nih.gov/pubmed/32392661 http://dx.doi.org/10.3904/kjim.2020.139

Ejemplares similares

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
por: Hattori, Yasushi, et al.
Publicado: (1995)

Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer
por: Wang, Yaping, et al.
Publicado: (2020)

The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
por: Shen, Hongzhang, et al.
Publicado: (2021)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993)

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2022)

Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
por: Qin, Yuan, et al.
Publicado: (2023)

Gastric neoplasms and pepsinogen phenotypes.
por: Ellis, A., et al.
Publicado: (1982)

Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen
por: Lee, Hyun Seok, et al.
Publicado: (2018)

Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study
por: Park, Seon Cheol, et al.
Publicado: (2019)

Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China
por: Liu, Xujuan, et al.
Publicado: (2021)

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population
por: Cai, Hao-Lei, et al.
Publicado: (2021)

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis
por: Huang, Ya-kai, et al.
Publicado: (2015)

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”
por: MIKI, Kazumasa
Publicado: (2011)

Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method
por: FURIHATA, Chie
Publicado: (2021)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study
por: Tong, Yuling, et al.
Publicado: (2021)

Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer
por: Alikhani, Mehdi, et al.
Publicado: (2021)

Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis
por: Chen, Lingli, et al.
Publicado: (2021)

Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
por: Yen, Hsu-Heng, et al.
Publicado: (2019)

Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
por: Zeng, Weiwei, et al.
Publicado: (2020)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
por: Hosseini, Mosalreza, et al.
Publicado: (2013)

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
por: Eriksen, Ann C., et al.
Publicado: (2019)

Pepsinogen and Pepsin
por: Herriott, Roger M.
Publicado: (1962)

Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis
por: Terasawa, Teruhiko, et al.
Publicado: (2014)

Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
por: Robles, Claudia, et al.
Publicado: (2022)

Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy
por: Mezmale, Linda, et al.
Publicado: (2019)

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China
por: Zhang, Xiao-mei, et al.
Publicado: (2014)

Tea Polyphenol Intake and Changes in Serum Pepsinogen Levels
por: Hamajima, Nobuyuki, et al.
Publicado: (1999)

Long-term Effect of Smoking on Serum Pepsinogen Values
por: Kikuchi, Shogo, et al.
Publicado: (2007)

Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
por: Razuka-Ebela, Danute, et al.
Publicado: (2022)

Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease
por: Li, Ping, et al.
Publicado: (2013)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population
por: Zoalfaghari, Abbas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j1ac24m21haf5seb02gjle9460